[{"id":"0ad91159-5e74-4841-9bb6-f71f53c01cf6","acronym":"","url":"https://clinicaltrials.gov/study/NCT07181720","created_at":"2025-09-20T07:06:00.818Z","updated_at":"2025-09-20T07:06:00.818Z","phase":"Phase 1","brief_title":"Safety and Efficacy of CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors: A Clinical Trial","source_id_and_acronym":"NCT07181720","lead_sponsor":"Chongqing Precision Biotech Co., Ltd","biomarkers":" CD70","pipe":"","alterations":" ","tags":["CD70"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • CD70 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 90","initiation":"Initiation: 09/12/2025","start_date":" 09/12/2025","primary_txt":" Primary completion: 03/31/2028","primary_completion_date":" 03/31/2028","study_txt":" Completion: 05/31/2028","study_completion_date":" 05/31/2028","last_update_posted":"2025-09-18"},{"id":"f9628c79-7324-4e87-a00c-3015179c1f3f","acronym":"","url":"https://clinicaltrials.gov/study/NCT06215950","created_at":"2024-01-22T17:19:42.966Z","updated_at":"2024-07-02T16:35:22.759Z","phase":"Phase 1","brief_title":"A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer","source_id_and_acronym":"NCT06215950","lead_sponsor":"Chongqing Precision Biotech Co., Ltd","biomarkers":" CD70","pipe":"","alterations":" ","tags":["CD70"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CD70 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 01/10/2024","start_date":" 01/10/2024","primary_txt":" Primary completion: 12/31/2026","primary_completion_date":" 12/31/2026","study_txt":" Completion: 12/31/2027","study_completion_date":" 12/31/2027","last_update_posted":"2024-01-22"},{"id":"aea53f71-450f-4f70-b26a-ec60ce665fd4","acronym":"","url":"https://clinicaltrials.gov/study/NCT06010875","created_at":"2023-08-25T15:08:21.321Z","updated_at":"2024-07-02T16:35:29.927Z","phase":"Phase 1","brief_title":"A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors","source_id_and_acronym":"NCT06010875","lead_sponsor":"Chongqing Precision Biotech Co., Ltd","biomarkers":" IL6 • CD70","pipe":" | ","alterations":" CD70 expression","tags":["IL6 • CD70"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD70 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CD70 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 11/30/2023","start_date":" 11/30/2023","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 09/30/2026","study_completion_date":" 09/30/2026","last_update_posted":"2023-11-08"},{"id":"b39d06d8-a44b-42df-b66d-73b2afe00351","acronym":"","url":"https://clinicaltrials.gov/study/NCT05518253","created_at":"2022-08-26T11:59:07.710Z","updated_at":"2024-07-02T16:35:39.465Z","phase":"Phase 1","brief_title":"A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors","source_id_and_acronym":"NCT05518253","lead_sponsor":"Weijia Fang, MD","biomarkers":" IL6 • CD70","pipe":" | ","alterations":" CD70 expression","tags":["IL6 • CD70"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD70 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CD70 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 05/30/2022","start_date":" 05/30/2022","primary_txt":" Primary completion: 05/30/2024","primary_completion_date":" 05/30/2024","study_txt":" Completion: 05/30/2025","study_completion_date":" 05/30/2025","last_update_posted":"2023-08-21"},{"id":"041b80da-d322-4251-85ad-bc74493b1b44","acronym":"","url":"https://clinicaltrials.gov/study/NCT05468190","created_at":"2022-07-21T12:57:30.700Z","updated_at":"2024-07-02T16:35:39.664Z","phase":"Phase 1","brief_title":"A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T","source_id_and_acronym":"NCT05468190","lead_sponsor":"Chongqing Precision Biotech Co., Ltd","biomarkers":" IL6 • CD70","pipe":" | ","alterations":" CD70 expression","tags":["IL6 • CD70"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD70 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CD70 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 07/17/2022","start_date":" 07/17/2022","primary_txt":" Primary completion: 07/17/2024","primary_completion_date":" 07/17/2024","study_txt":" Completion: 07/17/2025","study_completion_date":" 07/17/2025","last_update_posted":"2023-08-17"},{"id":"74723d01-6fac-468b-9d9a-0098ac086d75","acronym":"","url":"https://clinicaltrials.gov/study/NCT05420545","created_at":"2022-06-15T15:55:30.045Z","updated_at":"2024-07-02T16:35:39.690Z","phase":"Phase 1","brief_title":"A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors","source_id_and_acronym":"NCT05420545","lead_sponsor":"Chongqing Precision Biotech Co., Ltd","biomarkers":" IL6 • CD70","pipe":" | ","alterations":" CD70 expression","tags":["IL6 • CD70"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD70 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CD70 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 12/31/2021","start_date":" 12/31/2021","primary_txt":" Primary completion: 12/31/2023","primary_completion_date":" 12/31/2023","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2023-08-17"},{"id":"abdbe93e-0aca-4bb6-a38b-acf7dc98d6fe","acronym":"","url":"https://clinicaltrials.gov/study/NCT05420519","created_at":"2022-06-15T15:55:29.531Z","updated_at":"2024-07-02T16:35:39.788Z","phase":"Phase 1","brief_title":"Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer","source_id_and_acronym":"NCT05420519","lead_sponsor":"Chongqing Precision Biotech Co., Ltd","biomarkers":" IL6 • CD70","pipe":" | ","alterations":" CD70 expression","tags":["IL6 • CD70"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD70 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CD70 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 12/31/2021","start_date":" 12/31/2021","primary_txt":" Primary completion: 12/31/2023","primary_completion_date":" 12/31/2023","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2023-08-17"}]